07:44 AM EDT, 06/05/2025 (MT Newswires) -- Aurora Cannabis ( ACB ) said Thursday it has expanded its IndiMed brand in Australia with the launch of IndiMed Tempo 22, available through its subsidiary, MedReleaf Australia.

IndiMed remains one of the most prescribed medical cannabis brands for patients in Australia, Aurora said in a statement.

"Expanding our portfolio in the value segment in Australia reinforces our commitment to meet increasingly diversified patient needs with accessible, high-quality medical cannabis options," said Andre Jerome, executive vice president, global business development. "As a global leader in medical cannabis, we're proud to offer a diverse range of products that reflect both local demand and our dedication to innovation worldwide."

The company's shares were last seen down US$0.06, to US$5.51, in U.S. pre-market trading.